Earnings Call · Q1 FY2021·2021-05-05

Q1 21EPS +6.56%·Rev n/aQ4 20EPS -28.38%·Rev n/aQ3 20EPS +14.63%·Rev n/aQ2 20EPS +3.62%·Rev n/a⚠ consensus missing

Atara Biotherapeutics, Inc. ATRA

Eric Hyllengren — Vice President

Pascal Touchon — Chief Executive Officer

Jakob Dupont — Senior Executive

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ATRA calls or request research access.

More ATRA calls Browse calls Request research access